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Edited by Varda RotterAbstract Synthetic peptides with the arginine-glycine-aspartate
(RGD) motif have been used widely as inhibitors of integrin–li-
gand interactions to study cell growth, adhesion, migration and
diﬀerentiation. We designed cyclic-RGD peptide (Tpa-
RGDWPC-, cRGD) which could cause cell death in MCF-7 cell
line. In order to understand the mechanism involved in cRGD-in-
duced apoptosis, we used microarray, real-time quantitative
PCR (Q-PCR) and bioinformatics to study the eﬀects of cRGD
on breast cancer cell line MCF-7. By time-series gene expression
measurements and our developed software BSIP and GeneNet-
work, we reconstructed an apoptosis-related gene network. In
the network, caspase-9, located at the upstream, activates down-
stream eﬀector caspases such as caspase-7, leading to the induc-
tion of caspase-4. Combined our previous proteomics data with
newly performed docking simulation, it indicated that the cell
death induced by cRGD may be triggered through blocking inte-
grin signaling to the extracellular matrix and activation of cas-
pase pathway. This study provides a molecular explanation of
cRGD treatment in breast cancer cells and set forth a construc-
tive far-reaching impact on breast cancer therapy.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Apoptosis is a programmed cell death involved in many
physiological and pathological regulations [1]. Defective regu-
lation of apoptosis leads to a variety of human diseases includ-
ing cancer, autoimmune diseases and neurodegenerative
disorders [2]. Currently, understanding of apoptosis mecha-
nisms has resulted in new strategies for treating certain ill-
nesses, and several clinical testing are undergoing. ApoptosisAbbreviations: Tpa-RGDWPC, cRGD; Q-PCR, quantitative PCR
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doi:10.1016/j.febslet.2007.06.067is typically accompanied by the activation of a class of death
proteases called caspases. The apoptotic pathway is consisted
of several triggers, modulators and eﬀectors. Loss of adhesion
of integrins to their ligands is one such trigger. Integrins are
heterodimeric cell surface receptors that mediate cell–cell and
cell–extracellular matrix (ECM) interactions. Functions of
integrins have been shown to be involved in several important
cellular processes, including cell diﬀerentiation, angiogenesis,
apoptosis, cell migration, and tumor growth [3].
Synthetic peptides with the arginine-glycine-aspartate
(RGD) motif have been used widely as inhibitors of inte-
grin–ligand interactions in studies of cell adhesion, migration,
growth, and diﬀerentiation [4,5]. Recently, RGD peptides have
also been found to induce apoptosis in cells such as MDCK
cells [6], glomerular mesangial cells [7], and lymphocytes [8].
Former evidence shows that RGD-containing peptide may in-
duce an anchorage-independent apoptosis of HL60 cells and T
cells by entering into the cell and directly promoting caspase-3
activation [5,9,10]. Buckley et al. showed that the breast carci-
noma cell line MCF-7 with a functional deletion of the cas-
pase-3 gene was not inhibited in cell growth after RGD
peptides treatment [5]. However, our previous report [11]
shows MCF-7 suﬀered apoptosis after the treatment of our de-
signed cyclic Tpa-RGDWPC (cRGD). This gives rise to the
question, how cRGD inhibits cell growth of MCF-7 cells by
apoptotic pathway. We used a systems biology approach com-
bining with microarray, real-time quantitative PCR (Q-PCR)
and bioinformatics techniques to understand the molecular
mechanism of the cRGD induced apoptosis in MCF-7 cells.
With time-series gene expression measurements and our devel-
oped software, GeneNetwork and BSIP, an apoptosis-related
gene network has been reconstructed.2. Materials and methods
2.1. Synthesis of cyclic RGD
Cyclic RGD peptide (cyclic-3-mercaptopropionic acid-Arg-Gly-
Asp-Trp-Pro-Cys) (Fig. 1) was synthesized by solid-phase Fmoc
chemistry using Rink amide resin. The crude peptide was puriﬁed by
RP-HPLC C18 preparative column (10 mm · 250 mm); H2O contain-
ing 0.1% TFA/acetonitrile containing 0.1% TFA from 95/5 to 5/95 in
30 min with a ﬂow rate of 4 ml/min. The purity (>90%) was determined
by analytical C18 HPLC and mass spectrometry.blished by Elsevier B.V. All rights reserved.
Fig. 1. The structure of cRGD.
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In order to further understand the interaction of RGD with integrin,
a docking experiment was performed using the receptor molecular
model and docking protocol as described previously [12]. This proto-
col, using the shape-based docking algorithm LigandFit [13], consists
of the ﬂexible ﬁtting of the ligand (cRGD) within a rigid receptor (inte-
grin- PDB entry 1L5G). The obtained poses were subsequently scored
using the scoring function, LigScore [14]. The best pose was then en-
ergy minimized with CHARMm [15], allowing full ﬂexibility for the li-
gand and only side-chain ﬂexibility for the receptor. All calculations
were carried out in the Discovery Studio 1.6 environment (Accelrys,
San Diego, CA).
2.3. Cell culture
Human breast cancer MCF-7 cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (Atlanta Biologicals, GA, USA) supple-
mented with 10% fetal bovine serum (Gibco BRL, NY, USA), 1.5 g/l
sodium bicarbonate (Atlanta Biologicals), 4.5 g/l glucose, 4 mM L-glu-
tamine, 1 mM sodium pyruvate, penicillin (100 U/ml), streptomycin
(100 lg/ml), and amphotericin B (0.25 lg/ml, Atlanta Biologicals).
Cells were cultured at 37 C in an incubator with humidiﬁed atmo-
sphere of 5% CO2 in air.
2.4. RNA extraction
Total RNA was extracted from cyclic-RGD-treated (1 mM) and
non-treated MCF-7 cells. Brieﬂy, the cultured cells were harvested
and lysed with Trizol reagent (Invitrogen, Carlsbad, CA) following
the manufacturer’s instructions. The puriﬁed RNA was quantiﬁed by
a UV spectrophotometer, and RNA quality was evaluated by capillary
electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA).Table 1











All primers are listed 50–3 0.2.5. Time-course cDNA microarray
The data, both control and treated set, were obtained after cRGD
treatment at 6, 24, 48, 72 h to show the kinetics proﬁle of gene expres-
sion. Total RNA was reverse transcribed using the Agilent direct-label
cDNA synthesis kit (Agilent Technologies) and following the manufac-
turer’s directions. Labeled cDNA was puriﬁed using QIAquick PCR
Puriﬁcation columns (Qiagen, Valencia, CA). In this study, RNA from
cRGD treated MCF-7 cell was labeled with Cyanine 5-dCTP, and un-
treated one was labeled with Cyanine 3-dCTP. The combined Cy3- and
Cy5-labeled cDNAs were hybridized to an Agilent Human 1 cDNA
microarray according to the manufacturer’s protocol (Agilent Tech-
nologies). Subsequently, the arrays were scanned using a dual-laser
Microarray Scanner G2565AA (Agilent Technologies). Normalization
for each gene and comparative analysis between expression proﬁles
was carried out using GeneSpring version 7.3 (Silicon Genetics, Red-
wood, CA).2.6. Real-time Q-PCR
Total RNA was reverse-transcribed into cDNA by using an oli-
go(dT)20 primer and SuperScript III Reverse Transcriptase (Invitro-
gen). The speciﬁc gene primers for real-time PCR were designed
using the Beacon Designer 2.1 program (Premier Biosoft International,
Palo Alto, CA). Sequences are shown in Table 1. The real-time PCR
reaction (25 ll) containing 5 ll ﬁrst-strand cDNA, 12.5 ll iQ SYBR
Green supermix kit (Bio-Rad Laboratories, Hercules, CA) and 0.5 ll
(10 lM) of each sense and antisense primer was run for 40 ampliﬁca-
tion cycles in an iCycler iQ Real-Time PCR Detection System (Bio-
Rad Laboratories). Cycling conditions were 95 C for 3 min, 95 C
for 30 s, and 60 C for 30 s. Relative transcript quantities were calcu-
lated using the DDCt method with b-actin as the reference gene ampli-
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Signiﬁcance analysis of Q-PCR experiments was performed by
EDGE [16] which is a software tool based on optimal discovery proce-
dure and time course methodology for the signiﬁcance analysis of time-
course experiments.
2.8. Network construction
Based on the time-course Q-PCR data, we used our developed soft-
ware BSIP and GenNetwork [17] to construct the plausible gene regu-
latory network of cRGD-induced apoptosis in MCF-7 cells.
2.9. Western blotting
The proteins are extracted using lysis buﬀer containing 7 M urea
(Boehringer, Mannheim, Germany), 2 M thiourea, 4% CHAPS (J.T.
Baker, Phillipsburg, NJ, USA) and 0.002% bromophenol blue
(Amersco, OH, USA). After electrophoresis, proteins were blotted
onto polyvinyl-diﬂuoride membranes (MILLIPORE, MA, USA).
After blocking in 5% nonfat milk in PBST containing 0.1% Tween
20 (J.T. Baker) at room temperature 1 h with gentle shaking,
membranes were probed with antibodies. Primary antibodies involved
in this study include caspase-9 (Clone 96-2-22, Upstate, NY, USA) and
caspase-7 (Cell Signaling Technology, Inc., MA, USA) both diluted in
1:1000. Membranes were incubated with corresponding primary
antibody and then incubated with secondary antibodies (anti-mouse
IgG-HRP, 1:5000 dilution, Abcam, Cambridge, UK). After incubation
with secondary antibodies, immunoblots were visualized with the
ECL detection kit (Pierce Biotechnology Inc., IL, USA) and exposedFig. 2. Binding mode of cRGD with integrin (PDB code: 1L5G). (A) cRGD
charged (red), and positively-charged (blue) surfaces. The picture is prepared
with integrin by RGD residue. The picture is prepared with Discovery Stud
Fig. 3. A pie chart representing the distribution of functional classiﬁcations o
Gene Ontology assignments generated by GeneSpring software. (A) Genes
biological process showed in percentages. (B) 253 of these genes which are rto Fuji medical X-ray ﬁlm. b-Actin was used as an internal loading
control.3. Results
3.1. Protein–ligand interaction estimated by docking simulation
In order to further understand the interaction of RGD with
integrin, the docking experiments were performed on the Dis-
covery Studio 1.6 environment. The output convergent confor-
mations demonstrated that our designed cRGD has a reliable
binding aﬃnity to integrin interface. The predicted integrin–
cRGD complex conformation was illustrated in Fig. 2A. The
RGD sequence makes the main contact area with the integrin,
and each residue participates extensively in the interaction.
The RGD residues which formed hydrogen bonds with inte-
grin b subunit interacted with Asp127, Asn313, and Arg248
residues (Fig. 2B).
3.2. Gene expression proﬁles induced by cRGD in MCF-7
To identify genes involved mainly in apoptosis, and to com-
pare the diﬀerence of gene expression in treated cells and un-
treated ones, we utilized a complimentary DNA microarrayis docked in the integrin active site. Hydrophobic (white), negatively-
with PyMol [23]. (B) The cRGD molecule is formed hydrogen bond
io 1.6 environment.
f cRGD-treated human breast carcinoma cell line MCF-7 based on the
that were expressed at each stage after treatment, and clustered by
elated to apoptosis.
Table 2
Fold change of caspase gene expression
Description Genebank
accession no.
6-h-fold change 24-h-fold change 48-h-fold change 72-h-fold change
Caspase 4, apoptosis-related cysteine protease U28976 1.198754 1.389036 1.52571 2.511147
Caspase 6, apoptosis-related cysteine protease U20536 0.928076 0.948146 0.965973 0.464663
Caspase 7, apoptosis-related cysteine protease U67319 1.175194 1.201633 1.115639 1.391235
Caspase 9, apoptosis-related cysteine protease U60521 1.005501 1.091598 1.628327 1.171525
3520 T.-C. Huang et al. / FEBS Letters 581 (2007) 3517–3522carrying approximately 13000 human genes. Transcription
proﬁles were monitored 6, 24, 48 and 72 h after the onset of
treatment. From the analysis of cDNA microarray data, genes
shown in Fig. 3 were found to be either 2-fold up- or down-
regulated in at least one of four time points compared with
control samples. For an overall functional interpretation of
the common responses, these genes were sorted into groups
according to their gene ontology (GO) database categories
for biological processes (GO: http://www.geneontology.org).
This database provides annotations regarding the functions
and signaling of each gene. Pie charts were then constructed
to present the data. These genes which were categorized into
classes based on GO were represented in percentage
(Fig. 3A). cRGD regulates the expression of genes associated
with a broad range of biological process. The largest group
of genes is associated with ‘‘cellular process’’, while ‘‘physio-
logical process’’ and ‘‘regulation of biological process’’ are
the next most abundant groups of gene annotations. ThereTable 3
Time-course caspase gene expression measured by real-time Q-PCR experim
15 min 30 min 1 h 2 h 3 h
CASP 4 0.97 ± 0.05 0.69 ± 0.1 1.87 ± 0.18 0.79 ± 0.12 1.23
CASP 6 1.15 ± 0.11 0.76 ± 0.07 1.23 ± 0 0.87 ± 0 1.00
CASP 7 1.07 ± 0 0.79 ± 0.12 1.11 ± 0.05 0.79 ± 0.04 1.52
CASP 9 1.04 ± 0.05 0.87 ± 0.09 1.28 ± 0.06 0.62 ± 0.06 1.32
8 h 9 h 10 h 12 h 24 h
CASP 4 1.19 ± 0.06 1.23 ± 0.12 0.84 ± 0.04 4.61 ± 0.45 2.3
CASP 6 1.32 ± 0 1.46 ± 0.07 1.19 ± 0.06 2.22 ± 0.11 1.19
CASP 7 0.87 ± 0.09 1.00 ± 0.1 1.07 ± 0 2.46 ± 0 2.55
CASP 9 1.57 ± 0.08 1.68 ± 0.08 1.47 ± 0.22 1.75 ± 0.17 1.15
Fig. 4. Gene network construction. Two plausible gene regulatory network
similar gene regulation topology.are 253 genes related to apoptosis (Fig. 3B). The genes have
been generated with speciﬁc importance in ‘‘regulation of
apoptosis’’, ‘‘apoptosis’’, and ‘‘programmed cell death’’. Sev-
eral apoptosis-related genes such as caspase genes, bcl2,
TNF receptor-associated factor 3, interleukin 1b, and protein
kinase C e represented diﬀerential expressions in the micro-
array proﬁle (data not shown). Among them, the caspase genes
we are interested in were shown in Table 2. Accordingly, we
focused on the major caspase family genes, listed from cas-
pase-1 to 10, and verify the increasing expression of these
genes by real time PCR analysis.
3.3. Real-time PCR conﬁrms the microarray results
Several caspase genes were found in the microarray proﬁle.
To determine whether caspases are involved in cRGD induced
cell death, and to further validate the microarray results, we
used quantitative real-time PCR to examine the eﬀect of
cRGD on caspase genes. RNA samples from each time pointents
4 h 5 h 6 h 7 h
± 0 2.22 ± 0.11 1.32 ± 0 1.07 ± 0 1.57 ± 0.08
± 0.1 1.42 ± 0.14 1.23 ± 0.12 0.93 ± 0 1.37 ± 0.07
± 0 1.01 ± 0.2 1.04 ± 0.05 0.93 ± 0 1.15 ± 0.11
± 0 1.68 ± 0.08 1.07 ± 0 1.11 ± 0.05 1.63 ± 0.16
36 h 48 h 60 h 72 h
± 0 0.73 ± 0.04 1.07 ± 0 0.45 ± 0.02 1.07 ± 0.11
± 0.06 0.68 ± 0.03 1.19 ± 0.06 0.56 ± 0.08 1.15 ± 0
± 0.12 0.93 ± 0 1.46 ± 0.07 0.45 ± 0.02 0.97 ± 0.05
± 0.11 1.32 ± 0 1.75 ± 0.17 1.00 ± 0.1 1.37 ± 0.07
s were reconstructed by (A) BSIP and (B) GeneNetwork. They share
Fig. 5. Western blot analysis of controlled and cRGD-treated MCF-7
cells. The proteins extracted from MCF-7 cells, with control and in 6,
24, 48, and 72 h after cRGD treatment, were separated by one-
dimensional electrophoresis (1DE), and then transferred onto PVDF
membrane, respectively. The Western blots were performed for
caspase-7 and caspase-9, respectively. Caspase-7 and caspase-9 were
cleaved into active forms in MCF-7 cells after cRGD treatment.
T.-C. Huang et al. / FEBS Letters 581 (2007) 3517–3522 3521were reverse-transcribed into cDNA and then quantitative
PCR was performed as described in Section 2. Values for each
gene were normalized to values obtained for b-actin and then a
ratio of treated to control was calculated. The statistical anal-
ysis using EDGE, caspase-4, -6, -7, and, -9 exhibited signiﬁcant
deferential expressions within time intervals (P < 0.05). Table 3
shows the averages of three separate experiments with the stan-
dard deviations.
3.4. Reconstruction of caspase-involved gene regulatory network
As more high-throughput time-series measurements become
available, various reverse engineering schemes have been
developed to reconstruct the functional interaction structure
from given time-series expression proﬁles [18,19]. The time-ser-
ies expression levels of the selected candidate genes, caspase-4,
-6, -7, and -9, were used to build up a potential gene interaction
network. The inferred novel putative response pathway is
shown in Fig. 4. Two software tools, GeneNetwork and BSIP,
revealed a comparable signaling pathway. Both results indicate
that the activation of caspase-9 will stimulate activation of cas-
pase-7 and caspase-6, and capase-4 is aroused by activated ca-
pase-7. There are some positive feedback loops designated in
Fig. 4B: caspase-9 and caspase-6, caspased-7 and caspase-4,
and auto-activation of caspase-4.
3.5. Modulation of caspases in protein level
To investigate the modulation of caspases in protein level,
we performed western blot analysis for caspase-7 and cas-
pase-9. The proteins extracted from MCF-7 cells in control
and at 6, 24, 48 and 72 h after cRGD treatment were separated
by one dimensional electrophoresis, and then transferred onto
PVDF membrane, respectively. Caspase-7 and caspase-9 in
MCF-7 cells were cleaved into active forms after cRGD treat-
ment, as shown in Fig. 5. Our results showed that caspase-7, as
well as caspase-9, were up-regulated both in the level of tran-
script and protein for cRGD-treated MCF-7 cells. This indi-
cates that the cell death caused by cRGD may be triggered
through activation of caspase-7 and caspase-9.4. Discussion
Synthetic peptides containing the RGD motif have been
used extensively as inhibitors of integrin–ligand interactions[5]. By docking simulation, the cyclic RGD we designed shows
a reliable binding aﬃnity to integrin heterodimeric interface. It
indicates that cRGD might be a potent drug for good binding
aﬃnity to tumor cells membrane. The microarray study of
cRGD in MCF-7 provided the ﬁrst clue of which genes are
modulated. To our knowledge, the induction of caspases genes
family in MCF-7 by cRGD is somewhat surprising and has not
yet been reported before. Previously we found that cRGD in-
duced a typical apoptosis in MCF-7 human breast carcinoma
cancer cells [11]. Here, we continued our investigation on
cRGD-induced apoptosis in MCF-7 cell line. The breast can-
cer cell line MCF-7 was chosen because of the lack of func-
tional caspase-3 protein in this cell line. According to the
typical RGD-induced apoptosis, caspase-3 is a key molecule
regulating the signaling [5]. It would be important and interest-
ing if we conduct a newly found caspase-3-independent apop-
totic signaling pathway via integrin stimulation.
Our previous report [11] shows MCF-7 suﬀered apoptosis
after the treatment of our designed cyclic Tpa-RGDWPC
(cRGD). Additionally, there were several integrin-mediated
proteins that were down-regulated in protein diﬀerential
expression proﬁle. By docking simulation, we found that
cRGD can be docked in the integrin active site. These suggest
that cRGD may mimic the RGD-binding motif of integrin-
binding ligands to bind to integrin. However, this binding
could not induce the signal pathway involved in cell growth
and proliferation. Instead, cytocrhome c was released from
mitochondrial intermembrane space and activated caspase-9
[20]. From cDNA microarray data and real-time Q-PCR anal-
ysis, several caspase genes were activated sequentially after the
treatment of cRGD. And then the reconstruction of caspase
gene network is conducted by time series data. In the network,
caspase-9, located at the upstream, activates downstream eﬀec-
tor caspase-7. The activation of caspase-9 is believed to be a
well-deﬁned outcome of the release of mitochondrial cyto-
chrome c into the cytoplasm and its subsequent association
with the Apaf-1 protein. The assembly of cytochrome c,
Apaf-1 and procaspase-9, called apoptosome, triggers the acti-
vation of caspase-9 [21]. Subsequently, caspase-7 is directly
activated by the Apaf-1-caspase-9 apoptosome [22]. This indi-
cates that the cell death caused by cRGD may be triggered
through activation of caspase pathway. Our results provide a
molecular explanation of cRGD treatment in breast cancer
cells and set forth a constructive far-reaching impact in breast
cancer therapy.
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